is a ubiquitous environmental contaminant with well-known adverse effects in fish. In this study, we initially exploited suppression subtractive hybridization (SSH) as a screening tool to assess qualitative gene expression changes in whole brain, liver, and testis of adult male Japanese medaka (Oryzias latipes) exposed for 48 h to a single intraperitoneal-injected dose of TCDD (10 µg-TCDD/kg-body weight). Across these three organs, SSH identified a total of 335 unique genes. Each set of forward-and reversesubtracted organ cDNA libraries consisted of a distinct gene list and corresponding distribution of biological processes, suggesting that transcript profiles of these libraries were highly organspecific. Based on sequence match significance and frequencies within each set of organ libraries, genes hypothesized to be strongly responsive (42 total) within male medaka brain, liver, or testis were semi-quantitatively screened using replicate cDNA nylon membrane arrays.
INTRODUCTION
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD or dioxin) is a widely studied polychlorinated aromatic compound known to induce adverse affects in humans and wildlife, including cancer, reproductive and developmental effects, immunotoxicity, and cardiovascular disease (DeVito and Birnbaum, 1994; Jokinen et al., 2003) . TCDD is a lipophilic, bioaccumulative pollutant ubiquitous in the environment (Zook and Rappe, 1984) . Upon entry into cellular cytosol, TCDD is highly specific for the aryl hydrocarbon receptor (AHR), leading to dissociation of an inhibitory complex consisting of HSP90, p93, and XAP2 (Matsumura, 2003) . Following ligand binding, activated AHR enters the nucleus and forms a heterodimer with AHR nuclear translocator (ARNT); this transcription factor complex binds to dioxin response elements (DREs) in promoter regions of target genes, driving activation of the "Ah gene battery" [cytochrome p450 1A1 (CYP1A1), cytochrome p450 1A2 (CYP1A2), NAD(P)H:quinone oxidoreductase, aldehyde dehydrogenase 2 (ALDH3A1), UDP-glucuronosyl transferase (UDPGT), and glutathione Stransferase] (Matsumura, 2003; Nebert et al., 2000) , and regulation of numerous yet unidentified dioxin-inducible genes. Moreover, TCDD mediates numerous biological effects via AHRindependent pathways, as has been documented with several intermediate-early protooncogenes in mouse hepatoma cells (Hoffer et al., 1996) . In general, these direct and indirect TCDD-induced signaling pathways elicit down-stream adverse effects such as oxidative stress (Senft et al., 2002) , cell cycle arrest (Marlowe et al., 2004) , and apoptosis (Cantrell et al., 1998; Dong et al., 2004; Kamath et al., 1997; Toomey et al., 2001) .
In recent years, genome-wide expression analysis has been exploited in vitro (Adachi et al., 2004; Frueh et al., 2001; Puga et al., 2000) and in vivo (Kurachi et al., 2002) to uncover 4 additional AhR-dependent or -independent TCDD-responsive genes. However, the majority of these studies have centered on gene expression analysis in TCDD-exposed hepatoma cells or liver. To our knowledge, wide-scale gene expression analysis has not been thoroughly investigated with extra-hepatic organs affected by TCDD. Moreover, although much research has focused on acute and chronic dioxin toxicity in fish model systems (Hahn, 2001) , and several research groups have significantly advanced gene microarray technology for ecotoxicological fish models (Denslow et al., 2004; Larkin et al. 2003; Oleksiak et al., 2002; Williams et al., 2003) , to date there are no published studies investigating organ-specific gene expression responses in fish following TCDD exposure.
To this end, we utilized suppression subtractive hybridization (SSH) as a screening tool to initially evaluate qualitative gene expression changes in male Japanese medaka (Oryzias latipes) organs (whole brain, liver, and testis) following intraperitoneal TCDD injection and exposure for 48 h. Currently, oligonucleotide-or cDNA-based microarrays are not commercially available for Japanese medaka. Similar to microarray-based gene expression analysis, SSH analysis provides qualitative evaluation of mRNA-level differences between control and toxicantexposed animal tissues. SSH relies on hybridization-dependent subtraction of equally abundant transcripts and selective PCR-amplification and enrichment of differentially expressed transcripts (Diatchenko et al., 1996) . However, SSH is biased towards enrichment of transcripts that are highly abundant in one sample but not the other, and low abundant transcripts that are differentially expressed are not as likely to be identified (Ji et al., 2002) . Therefore, in this study, after SSH-based identification of differentially expressed transcripts, expression of genes suspected to be strongly responsive to TCDD was tested using organ-specific replicate nylon membrane arrays, and relative CYP1A and AHR1 transcript levels were measured by real-time RT-PCR. Moreover, qualitative histopathologic evaluation was used to relate organ pathology with gene expression patterns. Overall, we demonstrate that TCDD induces organ-specific at Pennsylvania State University on February 23, 2013 http://toxsci.oxfordjournals.org/ Downloaded from qualitative and semi-quantitative gene expression differences in male medaka, and that these differences are associated with histopathological changes.
MATERIALS AND METHODS
Chemicals. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (99.9 % purity) dissolved in 100% HPLC-grade dimethyl sulfoxide (DMSO) was a kind gift from Dr. F. Matsumura (University of California-Davis). Nominal TCDD stocks (3.5 mg/l) were prepared in DMSO and stored at -20ºC.
Test animals.
Oryzias latipes (Japanese medaka) is a small (3-4 cm) egg-laying freshwater fish native to Japan, Korea, and eastern China, and is a well-established developmental, genetic, and toxicological animal model (Law et al., 2003; Wittbrodt et al., 2002) .
Fish used for this study were collected from an orange-red line under standard recirculating aquaculture conditions. All fish were handled and treated according to protocols approved by the Duke Institutional Animal Care and Use Committee (IACUC).
TCDD exposures.
Adult male medaka (6-7 months old) (~350-mg body weight) were isolated to a separate aquarium tank and acclimated under recirculating culture conditions for 1 wk prior to injection. Fish were intraperitoneal (ip)-injected with a sterile, glass 25-µl Hamilton syringe equipped with an ultra-fine needle in the abdominal region with 1 µl HPLC-grade DMSO (vehicle) or 1 µl TCDD stock (3.5 ng/µl; ~10 µg-TCDD/kg-body weight nominal). For cDNA subtraction library generation, 6 fish per treatment were incubated static at 25ºC under 16:8 light:dark conditions for 48 h in ethanol-rinsed 2-l glass beakers containing sterile, embryo rearing medium (ERM) (17.1 mM NaCl, 272 µM CaCl 2 •2H 2 O, 402 µM KCl, 661 µM MgSO 4 •7H 2 O; pH 7.2) (Kirchen and West, 1976) . For cDNA macroarray and histopathological analysis, 12 fish per treatment were incubated static in 2 replicate, ethanol-rinsed 2-l glass beakers (6 fish per beaker) containing sterile ERM. For both experiments, fish were not fed and no mortalities or abnormal behavior were observed throughout the 48-h exposure period. At 6 test termination, medaka were removed and anesthetized in ice-cold ERM. Using scissors and forceps cleaned with RNaseZAP (Sigma) and 100% ethanol to reduce RNase contamination, organs (whole brain, liver, and testis) were removed and immediately frozen in liquid nitrogen.
Individual organs from six DMSO-or TCDD-exposed fish were pooled and used for generation of cDNA subtraction libraries (1 pool/treatment/organ); individual organs from four fish within each treatment replicate were pooled for cDNA macroarray analysis (2 pools/treatment/organ).
For the second experiment, the remaining 2 fish from each treatment replicate (4 fish total per treatment) were sacrificed for histopathological analysis.
Histopathological analysis.
At 48-h post-injection, DMSO-and TCDD-exposed male medaka were anesthetized in ice-cold ERM and peduncle transected caudal to the anus using clean forceps. Clean scissors were then used to open the abdominal cavity from rostral to the anus. This permitted fixative to make contact will all internal viscera. Fish were fixed in 2% paraformaldehyde/PBS (pH 7.4) for 72 h at 4ºC, and stored in 6% sucrose/PBS (pH 7.4) at 4ºC until mounting and sectioning. Fish were oriented in lateral recumbency, paraffin-embedded, and 6-8 µm thick-step sections through the whole body were mounted on glass slides and stained with hematoxylin and eosin. All animals were surveyed and imaged (40X and 100X) using a Nikon Eclipse E600 light microscope, a Nikon DXM 1200 digital camera, and EclipseNet imaging software (Nikon).
Total RNA isolation. For each treatment-specific RNA extraction, pooled organs (whole brain, liver, or testis) were homogenized with 1 ml RNA Bee (TelTest) using a stainless steel Polytron homogenizer (Kinematica) cleaned with RNaseZAP (Sigma), DEPC-treated water, and sterile de-ionized water. Following homogenization, 200 µl chloroform was added and the homogenate mixed vigorously for 30 s. The mixture was then chilled on ice for 5 min and centrifuged at 12000g at 4ºC for 15 min. The upper aqueous phase was transferred to a new 2-ml RNase-free tube containing 500 µl isopropanol and mixed well by inverting the tubes.
Samples were centrifuged at 12000g at 4ºC for 5 min, supernatant discarded, and RNA pellet was washed once by vortexing with 1 ml 75% ethanol. Following centrifugation at 7500g at 4ºC for 5 min, ethanol wash was removed and sample air-dried for 10 min. Resultant pellet was resuspended in 100 µl RNase-free water warmed to 52ºC. To eliminate DNA contamination, each sample was on-column-digested with DNase using an RNase-free DNase Set according to manufacturer's instructions (Qiagen), and eluted with 30 µl warmed (52ºC) RNase-free water.
RNA quantity and quality were verified using a NanoDrop ® ND-1000 spectrophotometer. Total RNA concentrations averaged 400-4500 ng/µl with 260/280 ratios ≥2.0.
Generation of subtraction libraries. Suppression subtractive hybridization was performed based on the original procedures of Diatchenko et al. (1996) . Following manufacturer's instructions, dsDNA was synthesized from 2 µg total RNA using a BD SMART™ PCR cDNA Synthesis Kit (BD Biosciences), and common-level cDNAs were subtracted and differentially expressed sequences were enriched using a Clontech PCR-Select™ cDNA Subtraction Kit (BD Biosciences). For each organ, subtracted cDNA libraries were generated in forward and reverse directions. cDNAs from the resultant libraries (2 libraries per organ) were inserted into pCR ® 2.1 vector (Invitrogen) and cloned using INVαF´ bacterial cells (Invitrogen).
Following overnight growth on agar plates, 384 individual bacterial colonies each for forwardand reverse-subtracted libraries (768 total colonies per organ) were individually transferred with sterile toothpicks to 96-well microplates containing 100 µl LB media with ampicillin (100 µg/ml) per well. Microplates were covered with breathable membranes (USA Scientific) and colonies grown overnight at 37ºC with constant agitation at 150 rpm. Following overnight growth, all isolated colonies were stored in 60% glycerol at -80ºC until differential screening.
Clones containing subtracted cDNAs were screened for false-positives using a PCR-Select Differential Screening Kit (BD Biosciences). Briefly, individual cDNA inserts were PCRamplified using 1 µl bacterial culture template and nested primers (NP-1 and NP-2R) provided by the manufacturer. PCR products (5 µl) were denatured at 65ºC for 5 min with 0.6 M NaOH, chilled on ice for 2-3 min, and spotted using a vacuum dot blotter in 96-well format on duplicate 8 positively-charged nylon membranes (75 mm X 115 mm) (Roche Diagnostics). Spotted membranes were neutralized in 0.5 M Tris/1.5 M NaCl for 4 min, rinsed in water for 2 min, and UV-cross-linked prior to drying and storage.
Each duplicate set of membranes was screened with probes from the appropriate organspecific forward-and reverse-subtracted cDNA library. Forward-and reverse-subtracted cDNA probes were generated at 37ºC for 60 min using [α 32 P] dATP (or dCTP) and purified using Microspin G-25 columns (Amersham Biosciences). Immediately following probe purification, probe radioactivity was quantified using a scintillation counter. Alternatively, reverse library probes were expected to hybridize to reverse library clones but not to forward library clones. In general, these predictions were true. However, some forward and reverse library probes hybridized equally to both library clones; these represented false-positive transcripts that were not differentially expressed between DMSO-and TCDD-treated organs.
Based on visual inspection of scanned membranes, only positive clones from both libraries for each organ showing a clear difference in hybridization were individually transferred with sterile toothpicks to new 96-well master microplates containing 100-µl LB media with ampicillin (100 µg/ml) per well. These colonies were re-grown overnight at 37ºC with constant agitation at 150 rpm. Following overnight growth, all isolated stock colonies were stored in 60% glycerol at -80ºC.
cDNA inserts from re-grown positive clones were PCR-amplified using reagents provided in the PCR-Select Differential Screening Kit (BD Biosciences). After PCR amplification, products Sequence reads with E<0.05 were assigned putative identities; all others were assumed to have no significant match with known sequences in NCBI databases. An E-value threshold of 0.05 was chosen since the probability of detecting a significant high-scoring sequence pair at the 95% confidence level is P = 1 -e -E (Karlin and Altschul, 1990 Tables 1, 2 , and 3), at least 42 sequences met these criteria and were picked for the cDNA macroarray (8 brain clones; 22 liver clones; 12 testis clones) (Tables 1 and 2 ). However, these arrays excluded 21 unique clones that met both criteria (Supplementary Tables 1, 2 , and 3) and all unknown (yet potentially novel)
sequences. For the 42-gene array, stock colonies were individually transferred in duplicate with sterile toothpicks to a 96-well microplate containing 100-µl LB media with ampicillin (100 µg/ml) per well and re-grown overnight at 37ºC with constant agitation at 150 rpm. Following overnight growth, all new stock colonies were stored in 60% glycerol at -80ºC until PCR amplification. All cDNA clones were simultaneously PCR-amplified in duplicate using a 96-well PCR plate. For each 75-µl PCR reaction, cDNA clones were PCR-amplified using 3 µl bacterial growth, 7.5 µl quantified in 1-µl aliquots using a NanoDrop ND-1000 UV/Vis Spectrophotometer (NanoDrop Technologies). Purified PCR products were diluted to 25 ng/µl with sterile water and purity checked on a 1.2% agarose gel. For each cDNA membrane array, 50 ng of purified cDNA was denatured at 65ºC for 5 min with 0.6 M NaOH and chilled on ice for 2-3 min; 25 ng were duplicate-spotted in 96-well format onto positively charged nylon membranes (75 mm X 115 mm) (Roche Diagnostics). Spotted membranes were neutralized in 0.5 M Tris/1.5 M NaCl for 4 min, rinsed in water for 2 min, and cDNAs UV-cross-linked prior to drying and storage. To assess intra-and inter-array variability, array controls were randomly spotted (25 ng/spot) on each membrane array. Array controls included: Arabidopsis Cab1 cDNA (Accession ID: X56062) (6 spots/array), salmon sperm DNA (2 spots/array), human Cot-1 DNA (2 spots/array), and human β-actin (2 spots/array) (Spot Report-3 Array Validation System, Stratagene). As 2 arrays per RNA pool were used for analysis, a total of 24 identical membrane arrays (8 arrays/organ) were spotted and stored in a dry, sealed environment at room temperature until hybridizations. , and 5.3X10 6 total cpm for brain-, liver-, and testis-specific arrays respectively) diluted in 100 µl blocking solution were hybridized to appropriate membrane arrays overnight while rotating at 72ºC. Membrane arrays were washed 4 times with 2X SSC/0.5% SDS for 30 min/wash, and 2 times with 0.2X SSC/0.5% SDS for 30 min/wash. Following washes, hybridized membranes were plastic-wrapped, exposed onto 35X43 cm phosphor screens for 72 h, and scanned using a Storm 860 Phosphoimager (Molecular Dynamics).
Statistical analysis of cDNA array data. Raw spot density data for each membrane were individually quantified by ArrayGauge v2.1 (FugiFilm), exported as a spreadsheet into Microsoft Excel, and coded by gene, treatment, treatment replicate, membrane replicate, and spot replicate. These hierarchical levels of identification were critical for appropriate statistical analyses outlined below. Spot intensity values on each membrane were normalized by dividing mean intensity values for salmon sperm DNA and Arabidopsis Cab1 on the same membrane.
As such, for each membrane, raw intensity values were individually adjusted for non-specific binding due to blocking agent (salmon sperm DNA) and differences in hybridization among membranes (Arabidopsis Cab1). These coded and normalized data were then imported into SAS v9.1 (SAS Institute Inc., Cary, NC) and outliers detected using a ROBUSTREG procedure (α=0.05). Outliers represented approximately 4-10% of the data depending on the array, and were generally due to random hybridization errors. After eliminating outliers from the entire data set, normalized values were tested for treatment-specific differences on a gene-by-gene basis using a mixed linear model (α=0.05) (a MIXED procedure in SAS) and multiple comparison of least square means (Wolfinger et al., 2001) . As these data were generated using a nested experimental design, we used a mixed model to account for variability linked with each level of hierarchy. This model handles unbalanced data (due to outlier elimination) and considers both fixed-and random-effects parameters associated with known a priori-assigned variables (gene and treatment) and unknown random variables (treatment replicate, membrane replicate, and spot replicate), respectively, assumed to impact the variability of the data. As this statistical model is conservative, significant treatment differences in array data were reported at the 90% confidence level (P<0.10).
Real-time RT-PCR. First-strand cDNAs were generated from the same mRNAs used for cDNA macroarrays. For each 20-µl reaction, total RNA (2 µg) was diluted with RNase-free water to a final volume of 10 µl, and 1 µl oligo(dT) 15 (500 µg/ml; Promega) and 1 µl 10 mM dNTPs were mixed with diluted RNA. The mix was heated to 65ºC for 5 min and chilled on ice for 2 min. Following centrifugation, 4 µl 5X first-strand buffer (Invitrogen), 2 µl 0.1 M DDT, and 1 µl RNase OUT Inhibitor (40 U/µl; Invitrogen) were added to each reaction and heated to 37ºC.
Following 2 min incubation, 1 µl Superscript Reverse Transcriptase (200 U/µl; Invitrogen) was added to each reaction and mRNA reverse transcribed at 37ºC for 1 h. All reactions were inactivated by incubating at 70ºC for 15 min. First-strand cDNAs were stored at -20ºC until realtime PCR.
Relative levels of CYP1A, AHR1, and β-actin transcripts were measured using real-time PCR. The following medaka-specific real-time PCR primers were designed using PrimerQuest Biosystems). For each sample, the threshold cycle for reference (β-actin) amplification (C t,β-actin )
was subtracted from the threshold cycle for target amplification (C t,CYP1A or C t,AHR1 ) to yield a ∆C t .
The threshold cycle represents the cycle number at which the fluorescence signal is significantly above the baseline. For each organ, the mean or standard deviation of ∆C t for DMSO-treated samples was subtracted from the mean or standard deviation of ∆C t for TCDD-treated samples to yield a mean and standard deviation of ∆∆C t for each target and organ. Fold induction relative to DMSO-treated organs and 95% confidence intervals were calculated using 2 -∆∆Ct .
RESULTS

Subtracted cDNA Library Identification, Annotation, and Characterization
Following exposure to TCDD (10 µg-TCDD/kg-body weight nominal) for 48 h, we generated brain-, liver-, and testis-specific forward-and reverse-subtracted cDNA libraries from male medaka using suppression subtractive hybridization, and 768 random colonies per organ (2304 total clones) were picked for false-positive differential gene expression screening. Following differential screening of each library, a total of 184, 335, and 261 positive clones in the brain, liver, and testis, respectively, were PCR-amplified and sequenced ( Table   3 ).
Of the 335 total genes identified among all three organs, only 2-3% of TCDD-responsive genes in all organs were shared between any two organs (Fig. 1) . Moreover, just 4 (1.2%) genes-CYP1A, ferritin, glyceraldehyde 3-phosphate dehydrogenase, and mitochondrial DNAwere identified in all three organs, suggesting a high degree of organ specificity at the level of gene expression in response to TCDD exposure (Fig. 1) . Following BLAST identification, genes identified within each organ were annotated by biological process based on Gene Ontology™ (GO) using LocusLink (http://www.ncbi.nlm.nih.gov/LocusLink/) (Pruitt and Maglott 2001) . Tables 1, 2 , and 3). Of the top six GO terms, genes involved in metabolism represented 31% (13 genes) and 32% (26 genes) of genes identified in the brain and liver (Fig. 2a and 2b ). Beyond metabolism, GO terms that dominated the brain included organogenesis (8 genes), protein transport (6 genes), unknown processes (6 genes), signal transduction (5 genes), and energy homeostasis (3 genes) (Fig. 2a) ; and GO terms that dominated the liver included unknown processes (15 genes), signal transduction (14 genes), immune response (12 genes), blood coagulation (9 genes), and proteolysis (6 genes) (Fig. 2b) . However, in the testis, 41% (50 genes) of identified genes had no known function (Fig. 2c) , with remaining dominant GO terms including proteolysis (16 genes), signal transduction (15 genes), metabolism (14 genes), cell proliferation (13 genes), and cell motility (12 genes).
cDNA Array Analysis of TCDD-exposed Medaka Brain, Liver, and Testis
As subtractive hybridization is not a reliable quantitative tool for evaluating gene ) and library frequency (f ≥ 2), 42 genes were picked for construction of cDNA macroarrays (Table 2) . For each treatment, 2 biological replicates consisting of 4 adult male medaka (6-7 months-old) per replicate were exposed to HPLC-grade DMSO (vehicle) or 10 µg-TCDD/kg-body weight. For each set of organ-specific hybridizations, there were no significant differences detected between internal controls (Arabidopsis Cab1) spiked into either DMSO-or TCDD-treated RNA (Table 2) .
Out of 42 genes, liver-derived CYP1A mRNA was the only transcript significantly higher (1.6-fold; P<0.06) in male medaka brain following a 48-h TCDD exposure (Table 2) .
Interestingly, although brain-derived CYP1A was also spotted on this array, no significant at Pennsylvania State University on February 23, 2013
http://toxsci.oxfordjournals.org/ Downloaded from treatment differences were detected. After sequence alignment of these two cDNAs to fulllength medaka CYP1A cDNA (total length = 2349 bp), brain-derived CYP1A cDNA spanned 194-735 bp whereas liver-derived CYP1A cDNA spanned 1662-2206 bp (data not shown). As the liver-derived CYP1A cDNA sequence was 3'-flanked, and reverse transcriptase is 3'-biased when generating 32 P-labeled cDNA, the cDNA pool likely consisted of a higher proportion of 3'-end-radiolabeled CYP1A. Accordingly, this may explain greater hybridization to spotted liver CYP1A and consequent TCDD-induced differences detected with liver-derived CYP1A but not brain-derived CYP1A.
In TCDD-exposed male medaka liver, 12 (29%) of 42 screened transcripts were significantly higher (P<0.10), and 5 of these transcripts were significant at α=0.05 (Table 2) ; no significantly responsive transcripts screened were lower in TCDD-exposed liver. As brain-and liver-derived CYP1A mRNAs were 1.6-and 2.5-fold higher, respectively (Table 2) , differences between these two CYP1A are likely attributable to 3'-biased reverse transcriptase as mentioned above. Interestingly, all statistically significant TCDD-responsive transcripts exhibited treatment:control ratios ≥1.19-fold, suggesting that conventional 1.5-or 2-fold threshold designations are not appropriate for array data in this study. Indeed, an arbitrary 2-fold threshold would have excluded 92% (11/12) of the significant responses in the liver. Five of 12 differentially expressed genes were originally identified in either brain or testis, and 15 of 22 liver-derived genes spotted onto this array were not significantly responsive (Table 2 ). This suggests that (1) suppressive subtraction hybridization failed to enrich for other TCDDresponsive liver genes identified in the brain or testis, and/or (2) signal detection on these arrays is limited.
In TCDD-exposed medaka testis, 34 (81%) of 42 screened transcripts were significantly lower (P<0.10); 17 of 34 were significant at α=0.05 and 11 of 34 were significant at α=0.01 (Table 2) . Significantly higher levels of transcripts were not detected in TCDD-exposed testis and no significant differences were detected with brain-or liver-derived CYP1A. In addition, 24
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http://toxsci.oxfordjournals.org/ Downloaded from of 34 differentially expressed genes were originally identified in either brain or liver (Table 2) , suggesting, as in the liver, that our subtracted testis cDNA libraries may not include additional genes potentially responsive to TCDD. Similar to liver, all significant TCDD-responsive transcripts exhibited treatment:control ratios ≤0.843, likewise suggesting that conventional 1.5-or 2-fold threshold designations are not appropriate for array data in this study.
Real-time RT-PCR analysis of CYP1A and AHR1 in TCDD-exposed Medaka Brain, Liver, and Testis
Real-time RT-PCR was used for relative quantitation of CYP1A and AHR1 transcripts in the same RNA used for cDNA macroarray hybridizations. Relative to DMSO-treated fish, mean CYP1A transcript levels were roughly 198-, 15-, and 1.5-fold higher in brain, liver, and testis, respectively, at 48 h following TCDD exposure (Table 3) . Thus, there were significant organdependent differences in CYP1A transcript levels at this sampling time and dose. Alternatively, compared to CYP1A, AHR1 was not significantly induced in TCDD-treated organs at 48 h, and did not exceed levels >2.0-fold in any of the organs (Table 3) .
Histopathological Changes in TCDD-exposed Medaka Brain, Liver, and Testis
Following exposure to DMSO or TCDD (10 µg-TCDD/kg-body weight nominal) for 48 h, eight paraformaldehyde-fixed male medaka were surveyed as described and alterations imaged. Representative sections of DMSO-or TCDD-exposed brain, liver, and testis are shown in Fig. 3 . No gross TCDD-induced histopathological effects were observed in the brain (Fig. 3A and Fig. 3B ). In TCDD-exposed liver, glycogen depletion was observed, while lipidosis was not observed at this TCDD dose and time-point in male medaka ( Fig. 3C and Fig. 3D ). Lastly, adverse TCDD-induced histological changes were most evident in the testis. These changes included disorganization of spermatogenesis at the testis periphery, disruption of the interstitium, Leydig cell swelling, and Sertoli cell vacuolation ( Fig. 3E and Fig. 3F ).
DISCUSSION
Our study demonstrates that a single ip-injected dose of 10 µg-TCDD/kg-body weight resulted in organ-specific differential gene expression and histopathological changes in male Japanese medaka (Oryzias latipes). To assess mRNA differences, we exploited suppressive subtractive hybridization (SSH) to enrich for chemically responsive genes in 48-h TCDD-treated male medaka brain, liver, and testis. As SSH favors enrichment of transcripts in high abundance and has a relatively high false-positive rate (Ji et al., 2002) , we initially screened 768 total forward-and reverse-subtracted clones within each organ to maximize detection and identification of TCDD-responsive genes. Of 2304 clones screened across all organs, approximately 66% (1524/2304) were identified as false-positives (those presumed to be nondifferentially expressed), and the remaining 44% (780) were putatively identified as differentially expressed transcripts. Following sequencing and BLAST-based identification, the forward-and reverse-subtracted liver and testis cDNA libraries contained roughly 2-and 3-times as many distinct transcripts, respectively, as the forward-and reverse-subtracted brain cDNA libraries.
Based on individual transcript occurrence within these cDNA libraries, differences were directly attributable to individual transcript frequency and library diversity. While CYP1A transcripts (28 occurrences) dominated the brain cDNA libraries, and hence decreased overall library diversity, high frequency transcripts (>5 occurrences) were more common in liver libraries, but were virtually absent in testis libraries. As a result, transcript profiles of these libraries were highly organ-specific, as indicated by the small degree of overlap of unique genes between any two organs, suggesting qualitative differences in mRNA responses following TCDD exposure.
However, qualitative differences warranted confirmation of a subset of genes hypothesized to be strongly responsive. Thus, based on transcript frequency and sequence match significance , we constructed a 42-gene array that incorporated cDNAs from each organ library.
For array-based analysis, a separate cohort of 6-7-month-old male medaka was exposed for 48 h to DMSO or TCDD as was initially done for subtraction library generation. Array results showed that expression of some of SSH-identified transcripts was significantly different between DMSO-and TCDD-treated brain, liver, or testis; however, within each organ, not all transcripts originally isolated from the respective organ were significantly responsive, suggesting that these arrays exhibited low sensitivity. Moreover, some significant differentially expressed transcripts within the liver and testis were not originally identified in that same organ, suggesting that SSH initially failed to enrich for some differentially expressed mRNAs. Thus, given these limitations of SSH, larger subtraction libraries need to be screened in order to maximize identification of TCDD-responsive genes.
Analysis of overall array data trends demonstrates that the number and significance of TCDD-responsive genes increased from brain-to-liver-to-testis, a finding that corroborates qualitative trends in mRNA library diversity (an increase in the number of unique genes identified) and histopathological changes (an increase in the degree of histological changes observed). In addition, relative to DMSO-treated fish, all significantly different transcript responses screened on these arrays were higher (up-regulated) in TCDD-treated brain and liver, while all significantly different responses were lower (down-regulated) in TCDD-treated testis. Therefore, TCDD-exposed male medaka brain, liver, and testis have significant qualitative and semi-quantitative differences in mRNA-level responses-including the direction of response (up-or down-regulated)-with putative associations with histopathological differences. However, as with many current toxicogenomic studies, accurate correlations of TCDD-induced gene expression changes with observed pathologies were not conclusive in this study. Indeed, since RNA was only isolated 48 h after TCDD treatment, gene expression responses at this time-point may be primary or secondary to histopathological changes.
In this study, we detected significantly higher CYP1A mRNA levels in TCDD-treated adult male medaka brain and liver based on cDNA array analysis and real-time PCR. Based on array data, liver CYP1A mRNAs were roughly 1.5-times higher than in brain, as was similarly observed in CYPLucR +/-mice treated with 3.2 µg-TCDD/kg-tissue for 24 h (Galijatovic et al., 2004) and Sprague-Dawley rats treated with 10 µg-TCDD/kg-tissue for 28 d (Huang et al., 2000) . However, based on real-time RT-PCR, relative brain CYP1A mRNAs were over 13-times higher than in liver, indicating that real-time RT-PCR was significantly more sensitive than arrays for detecting differences in CYP1A mRNA among organs. Although we did not localize CYP1A mRNA or protein on tissue sections, high CYP1A transcript levels in the brain are likely due to induction within the vascular endothelium rather than the parenchyma, as was reported in TCDD-exposed zebrafish embryos (Dong et al., 2002) . Interestingly, while CYP1A transcripts were induced 197-fold in the brain based on real-time RT-PCR, we observed no gross histopathological changes at 48 h. Likewise, while CYP1A mRNA and protein were strongly induced in all major brain regions (telencephlalon, diencephalon, mesencephalon, rhombencephalon, cerebellum, and pituitary) of gilthead seabream (Sparus aurata) after a 2-d static exposure to 6 pg-TCDD/l-seawater (Ortiz-Delgado et al. 2002) , no gross histopathological changes were reported.
As we did not identify AHR or ARNT transcripts in brain, liver, or testis subtraction libraries, AHR and ARNT mRNA were not measured by array analysis in this study. However, we measured AHR1 expression by real-time RT-PCR in the same samples used for array analysis, and found that, compared to CYP1A, AHR1 was not significantly induced in any organ.
Likewise, Huang et al. (2000) reported that AHR and ARNT mRNA levels in TCDD-treated rat liver were not significantly different from vehicle controls, and Tanguay et al. (2000) reported that TCDD did not induce dioxin responsive reporter gene expression in COS-7 cells expressing zebrafish ARNT2b or ARNT2c. Thus, due to minimal induction following TCDD exposure, SSH was not sensitive enough to enrich for AHR or ARNT isoforms in this study.
Based on cDNA array analysis of TCDD-exposed liver mRNA, we detected significantly (Nebert, 2000) . Thus, significantly higher levels of these transcripts detected in this study supported liver exposure to TCDD, while remaining differences (excluding male sex-determining protein) were likely related to acute-phase responses such as host defense and inflammation. Even at 48 h, we observed glycogen depletion in the liver.
Similar histopathological observations were reported in adult female rainbow trout (Oncorhynchus mykiss) liver after exposure to TCDD-spiked food (90 ng-TCDD/kg-food) for 100 days (Walter et al., 2000) and in adult male zebrafish (Danio rerio) liver after exposure to 70 µg-TCDD/g-tissue for 5 d (Zodrow et al., 2004) . Glycogen serves as a major glucose reserve in fish liver, and glycogen mobilization to the plasma occurs during high-energy demand situations such as starvation or stress (Hinton et al., 2001) . In this study, mRNA levels of α-amylase-an enzyme involved in glycogen metabolism in fish liver (Murat, 1976 )-were significantly higher in TCDD-exposed livers, suggesting that α-amylase played a role in glycogen mobilization and depletion in response to increased xenobiotic-related metabolic demand. Contrary to TCDDexposed zebrafish (Zodrow et al. 2004 ), we did not observe histopathological signs of lipidosis in the liver; however, the nominal dose used in the present study was 7-times less (70 vs. 10 µg/kg) and exposure time was less than half the duration (120 vs. 48 h). Thus, a 10 µg/kg ipinjected exposure for 48 h was not sufficient to induce lipid accumulation commonly observed in xenobiotic-exposed fish livers (Hinton, 2001 ).
To our knowledge, this is the first report of hepcidin and TBT-binding protein mRNA in medaka liver, and the only published demonstration of differential expression of these two genes following TCDD exposure. Hepcidin is a novel liver-derived antimicrobial peptide originally discovered in urine from human donors (Park et al., 2001) . This 20-25-amino acid peptide has since been identified in fish including hybrid striped bass (Morone saxatilis x M. chrysops) (Shike et al., 2002) , winter flounder (Pseudopleuronectes americanus) (Douglas et al., 2003) , Atlantic salmon (Salmo salar) (Douglas et al., 2003) , and zebrafish (Danio rerio) (Shike et al., 2004) , and is highly expressed in white bass (M. chrysops) liver following bacterial challenge (Shike et al., 2002) . Although the precise role of hepcidin in chemically induced liver toxicity is currently not established, hepcidin is known to be a key regulator of iron absorption and mediator of inflammation (Ganz, 2003) . In fish and mammals, iron metabolism and transport in liver is a well-known component of an acute phase response to toxicant exposure.
In this study, hepcidin was likely involved in immune-and/or inflammation-related pathways in TCDD-exposed medaka liver. Significantly higher mRNA levels of tributyltin (TBT)-binding protein were also detected in TCDD-exposed liver, but the precise function of this protein is currently unknown. TBT-binding protein is a serum-derived protein identified from TBT-exposed Japanese flounder (Paralichthys olivaceus), and is thought to play a role in xenobiotic transport throughout the fish vascular system (Shimasaki et al., 2002) .
Based on qualitative evaluation of histopathology and semi-quantitative cDNA array analysis, the most significant differences observed at 48 h were in TCDD-exposed male medaka testis. Morphological differences included disorganization of spermatogenesis at the testis periphery, disruption of the interstitium, Leydig cell swelling, and Sertoli cell vacuolation.
Similar adverse effects in the germinal epithelium have also been observed in rat testes 7 d
post-exposure to a single 3 µg/kg dose of TCDD (Rune et al., 1991) . Based on array data, significantly affected transcripts isolated from TCDD-treated whole medaka testes were decreased more than 1.2-fold and were associated with 21 known biological processes, suggesting that overall gene transcription in the testis was suppressed at 48 h following a single TCDD injection; however, significant differences in CYP1A and AHR1 mRNA were not detected between control and TCDD-treated male medaka testis based on arrays (CYP1A) and real-time PCR (CYP1A and AHR1), as was similarly observed in adult male rats (Roman et al., 1998) .
Thus, contrary to the liver, these data suggest that TCDD-induced gene expression responses and gross histopathological changes are putatively CYP1A-independent; however, based on (Latchoumycandane et al., 2003) . While our study only focused on acute effects, and medaka testes were likely able to recover following a single dose of TCDD, long-term TCDD-induced ROS generation may lead to apoptosis in a variety of cell types within the testis. Based on recent studies using terminal dideoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays, adult male medaka chronically exposed to 100 µg/L nonylphenol or 0.01 µg/L 17α-ethinylestradiol resulted in increased apoptosis of spermatocytes, Leydig cells, and Sertoli cells (Weber et al., 2002; Weber et al., 2004) . Likewise, long-term TCDD exposure may lead to cell death in Sertoli cells, Leydig cells, and/or immature germ cells of adult medaka. Moreover, persistent TCDD-induced toxicity to these cell types (especially during development) may lead to decreased mature spermatozoa numbers and male infertility. For instance, low TCDD doses (≤1.0 µg-TCDD/kg-tissue) during various stages of male rat development significantly decreased sperm production by more than half once sexual maturity was reached (Gray et al., 1995; Mably et al., 1992) .
Of those genes significantly responsive to TCDD, two genes-male sex-determining protein and protamine-are critical for testicular development and spermatogenesis in male medaka. In medaka, male sex-determining protein is a Y-linked DM-domain-containing gene required for testicular development (Matsuda et al., 2002) , and transcripts are normally expressed in Sertoli cells of adult male testis (Nanda et al., 2002) . As heritable mutations of male sex-determining protein in medaka results in XY female offspring (Matsuda et al., 2002) , TCDD-induced decreases of this protein in the testis may have the potential to disrupt spermatogenesis or induce long-term feminizing effects. In addition, male sex-determining protein transcripts were significantly higher in TCDD-exposed medaka liver, as has been reported with the mammalian ortholog SRY in TCDD-exposed HepG2 cells (Adachi et al., 2004) ; however, the role of liverderived sex-determining protein in medaka is currently unknown. Protamine is an arginine-rich, DNA-binding protein that replaces histones in maturing spermatids during nuclear condensation (Saiki et al., 1997) , and heritable mutations in the protamine gene disrupt nuclear formation, spermatogenesis, and infertility in male mice (Cho et al., 2001) . Thus, TCDD-induced decreases in protamine may have long-term effects on normal sperm maturation in male medaka.
Taken together, these findings demonstrate that TCDD induces organ-specific differential gene expression in adult male medaka, and these responses are generally associated with histopathological changes. After a 48-h 10 µg-TCDD/kg-tissue exposure, adverse effects at the mRNA-and histological-level increased from brain-to-liver-to-testis. In addition, we identified unique mRNA-level biomarkers of TCDD-induced hepatic and testicular toxicity in medaka that may be further pursued using focused monitoring approaches such as real-time PCR or in situ hybridization, as well as functional approaches such as drug-based inhibition or RNAi. a Fold induction and 95% confidence intervals relative to DMSO-treated fish.
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